alexa Histoplasmosis of the Central Nervous System | OMICS International | Abstract
E-ISSN: 2314-7326
P-ISSN: 2314-7334

Journal of Neuroinfectious Diseases
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Histoplasmosis of the Central Nervous System

David Trofa1 and Joshua D. Nosanchuk2,*

1School of Medicine, Tufts University, 136 Harrison Avenue, Boston, MA 02110, USA

2Department of Medicine (Infectious Diseases) and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA

*Corresponding Author:
Joshua D
Department of Medicine (Infectious Diseases)
and Department of Microbiology and Immunology
Albert Einstein College of Medicine, Bronx
NY 10461, USA
E-mail: [email protected]

Received Date: 4 June 2012 Revised Date: 2 August 2012 Accepted Date: 7 August 2012

Abstract

Histoplasmosis of the central nervous system (CNS) is not an uncommon complication of Histoplasma capsulatum infection since it occurs in ∼2% to 20% of disseminated cases. CNS histoplasmosis carries a mortality rate that ranges from 11.1% to 100%, and the risk factors for dissemination to the brain have yet to be determined. Diagnosis is often difficult and time consuming, which can result in delayed initiation of treatment. The recommended treatment for CNS histoplasmosis involves a high dose liposomal amphotericin B followed by maintenance azole therapy, usually for at least a year; however no comparative trials have been performed to prove efficacy of one regimen over another. Further, prospective and in vivo studies are necessary to more effectively combat this disease.

Keywords

Recommended Conferences

International Congress on Neurology

Auckland, New Zealand
Share This Page
Top